Literature DB >> 10233163

Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation.

A D Bradshaw1, A Francki, K Motamed, C Howe, E H Sage.   

Abstract

SPARC (secreted protein acidic and rich in cysteine)/BM 40/osteonectin is a matricellular protein shown to function as a counteradhesive factor that induces cell rounding and as an inhibitor of cell proliferation. These activities have been defined in cell culture, in which interpretation has been complicated by the presence of endogenous SPARC. We therefore sought to determine whether cell shape and proliferation would be affected by the absence of SPARC. Mesangial cells, fibroblasts, and aortic smooth muscle cells were isolated from SPARC-null and age-matched, wild-type mice. In contrast to wild-type cells, SPARC-null mesangial cells exhibited a flat morphology and an altered actin cytoskeleton. In addition, vinculin-containing focal adhesions were distributed over the center of SPARC-null cells, whereas in wild-type cells, the number of focal adhesions was reduced, and these structures were restricted largely to the cell periphery. Although the SPARC-null fibroblasts did not display overt differences in cell morphology, the cells responded to exogenous recombinant SPARC by rounding up in a manner similar to that of wild-type fibroblasts. Thus, the expression of endogenous SPARC is not required for the response of cells to SPARC. Additionally, SPARC-null mesangial cells, fibroblasts, and smooth muscle cells proliferated faster than their respective wild-type counterparts. Null cells also showed a greater sensitivity to the inhibition of cell cycle progression by the addition of recombinant SPARC. The increased proliferation rate of SPARC-null cells appeared to be mediated, at least in part, by an increase in the cell cycle regulatory protein cyclin A. We conclude that the expression of SPARC influences the cellular architecture of mesangial cells and that SPARC plays a role in the regulation of cell cycle in mesangial cells, fibroblasts, and smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233163      PMCID: PMC25344          DOI: 10.1091/mbc.10.5.1569

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  29 in total

Review 1.  Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information.

Authors:  C H Damsky; Z Werb
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

2.  SPARC induces the expression of type 1 plasminogen activator inhibitor in cultured bovine aortic endothelial cells.

Authors:  P Hasselaar; D J Loskutoff; M Sawdey; E H Sage
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

3.  SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.

Authors:  P Hasselaar; E H Sage
Journal:  J Cell Biochem       Date:  1992-07       Impact factor: 4.429

Review 4.  Vinculin.

Authors:  J J Otto
Journal:  Cell Motil Cytoskeleton       Date:  1990

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  The biology of SPARC, a protein that modulates cell-matrix interactions.

Authors:  T F Lane; E H Sage
Journal:  FASEB J       Date:  1994-02       Impact factor: 5.191

7.  The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.

Authors:  S E Funk; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.

Authors:  S E Funk; E H Sage
Journal:  J Cell Physiol       Date:  1993-01       Impact factor: 6.384

9.  The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.

Authors:  E W Raines; T F Lane; M L Iruela-Arispe; R Ross; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.

Authors:  T F Lane; E H Sage
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  21 in total

Review 1.  The Ehlers-Danlos syndrome: on beyond collagens.

Authors:  J R Mao; J Bristow
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

3.  Regulator of Calcineurin 1 Isoform 4 (RCAN1.4) Is Overexpressed in the Glomeruli of Diabetic Mice.

Authors:  Chorong Jang; Ji Hee Lim; Cheol Whee Park; Young-Jin Cho
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

4.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

5.  Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.

Authors:  Naohisa Tamura; Lynda K Doolittle; Robert E Hammer; John M Shelton; James A Richardson; David L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

6.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

7.  The SPARC-related factor SMOC-2 promotes growth factor-induced cyclin D1 expression and DNA synthesis via integrin-linked kinase.

Authors:  Peijun Liu; Jining Lu; Wellington V Cardoso; Cyrus Vaziri
Journal:  Mol Biol Cell       Date:  2007-11-07       Impact factor: 4.138

8.  SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

Authors:  Jing Nie; E Helene Sage
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

9.  Establishment condition and characterization of heart-derived cell culture in Siberian sturgeon (Acipenser baerii).

Authors:  Min Sung Kim; Yoon Kwon Nam; Chulhong Park; Hyun-Woo Kim; Jiyeon Ahn; Jeong Mook Lim; Seung Pyo Gong
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-07-23       Impact factor: 2.416

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.